To assess current medical surveillance monitoring practices for health care workers who prepare, handle, or administer hazardous medications.
A cross-sectional survey was distributed to members of the American College of Occupational and Environmental Medicine and the National Comprehensive Cancer Network.
Forty-six of the 91 survey respondents indicated that their institution had a hazardous medication surveillance program. We identified the most frequent laboratory (complete blood count) and physical (skin) examination components. A health history was frequently used. Statistical analysis did not suggest an association between institutions with greater resources and presence of a surveillance program.
A consensus standard for medical monitoring was not reported by the respondents. We recommend using a standardized surveillance questionnaire and applying uniform laboratory testing across institutions, in addition to establishing a national repository for surveillance data.
Division of Preventive, Occupational and Aerospace Medicine (Drs Breeher, Molella, Vaughn, Swift, and Newcomb); Department of Nursing (Ms Brueggen), Mayo Clinic, Rochester, Minnesota; Department of Health Sciences Research, Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Jacksonville, Florida (Dr Spaulding); and Division of Occupational Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania (Dr Green-McKenzie).
Address correspondence to: Laura E. Breeher, MD, MPH, Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (email@example.com).
Source of funding: This study was not externally funded.
Conflict of interest: None.
Supplemental digital contents are available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (www.joem.org).